Second-Line Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma: A Cost-Effectiveness Analysis

Amar H. Kelkar*, Edward R.Scheffer Cliff, Caron A. Jacobson, Gregory A. Abel, Stijntje W. Dijk, Eline M. Krijkamp, Robert Redd, Joanna C. Zurko, Mehdi Hamadani, M. G.Myriam Hunink, Corey Cutler

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Second-Line Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma: A Cost-Effectiveness Analysis'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions